🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 19 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 30/04/2014 | 40,94 | 41,93 | 39,10 | 39,41 | -4,03% | 6,92% | 646.490 |
| 29/04/2014 | 39,89 | 41,85 | 39,30 | 41,06 | +3,83% | 6,38% | 310.181 |
| 28/04/2014 | 40,93 | 41,62 | 37,19 | 39,54 | -2,64% | 10,82% | 781.783 |
| 25/04/2014 | 42,33 | 42,78 | 40,31 | 40,62 | -5,25% | 5,85% | 321.081 |
| 24/04/2014 | 43,46 | 43,57 | 40,84 | 42,87 | -0,67% | 6,27% | 459.099 |
| 23/04/2014 | 43,47 | 43,79 | 40,71 | 43,16 | -1,44% | 7,09% | 625.811 |
| 22/04/2014 | 41,32 | 43,96 | 41,32 | 43,79 | +6,69% | 6,40% | 627.735 |
| 21/04/2014 | 40,17 | 41,48 | 38,98 | 41,04 | +2,59% | 6,23% | 389.850 |
| 17/04/2014 | 39,00 | 41,30 | 38,23 | 40,01 | +1,96% | 7,89% | 583.652 |
| 16/04/2014 | 37,82 | 39,34 | 36,62 | 39,24 | +5,29% | 7,19% | 616.834 |
| 15/04/2014 | 37,64 | 38,92 | 34,87 | 37,27 | -0,71% | 10,76% | 573.553 |
| 14/04/2014 | 38,65 | 40,12 | 36,48 | 37,54 | -1,73% | 9,43% | 594.873 |
| 11/04/2014 | 39,53 | 41,51 | 38,07 | 38,20 | -4,22% | 8,71% | 588.622 |
| 10/04/2014 | 43,46 | 43,96 | 39,46 | 39,88 | -8,63% | 10,35% | 741.708 |
| 09/04/2014 | 41,48 | 43,79 | 41,41 | 43,65 | +5,69% | 5,73% | 405.559 |
| 08/04/2014 | 40,50 | 41,65 | 39,93 | 41,30 | +2,38% | 4,27% | 362.438 |
| 07/04/2014 | 39,30 | 41,15 | 38,62 | 40,34 | +2,59% | 6,44% | 581.889 |
| 04/04/2014 | 39,94 | 41,44 | 37,70 | 39,32 | -0,77% | 9,36% | 662.680 |
| 03/04/2014 | 41,18 | 41,20 | 39,18 | 39,63 | -3,77% | 4,92% | 376.224 |
| 02/04/2014 | 43,04 | 43,24 | 40,24 | 41,18 | -3,61% | 6,96% | 428.642 |
| 01/04/2014 | 41,97 | 43,29 | 41,75 | 42,72 | +1,80% | 3,66% | 370.934 |
| 31/03/2014 | 39,69 | 42,40 | 39,35 | 41,97 | +6,31% | 7,69% | 714.938 |
| 28/03/2014 | 42,66 | 43,14 | 39,08 | 39,48 | -7,23% | 9,54% | 793.645 |
| 27/03/2014 | 42,28 | 43,67 | 41,25 | 42,55 | +0,68% | 5,71% | 350.897 |
| 26/03/2014 | 43,25 | 44,25 | 42,26 | 42,26 | -1,07% | 4,60% | 342.080 |
| 25/03/2014 | 44,09 | 45,13 | 42,60 | 42,72 | -2,27% | 5,74% | 506.708 |
| 24/03/2014 | 45,03 | 45,43 | 41,60 | 43,71 | -2,84% | 8,51% | 919.801 |
| 21/03/2014 | 48,22 | 48,68 | 44,85 | 44,99 | -6,35% | 7,93% | 1.325.200 |
| 20/03/2014 | 48,56 | 49,46 | 47,77 | 48,04 | -0,85% | 3,48% | 252.473 |
| 19/03/2014 | 49,75 | 50,04 | 47,88 | 48,45 | -2,40% | 4,34% | 437.298 |